UTHealth Receives FDA Approval for Coronary Flow Reserve Quantification Software

 

August 21, 2012

cfrQuant is coronary flow reserve (CFR) quantification software from the University of Texas Health Science Center at Houston (UTHealth). The software was developed under the guidance of K. Lance Gould, M.D., and the Weatherhead PET Imaging Center of the UTHealth Medical School, with contributions of software segments from Positron Corp.

Positron distributes and supports cfrQuant to its current and future U.S.-based cardiac PET (positron emission tomography) customers, under a licensing agreement with UTHealth. The cfrQuant software has been approved for use with 82Rb-chloride and 13N-ammonia. Gould has recused himself of receiving royalties in support of academic programs.

The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant in August 2012.

For more information: www.positron.com